EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease

Naifa Lamki Busaidy, Maria E Cabanillas

Journal of Thyroid Research · 2012 · 2012 · 1-12

DOI: 10.1155/2012/618985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thyroid Research, 2012. Verfasst von Naifa Lamki Busaidy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1461, Houston,…. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Differentiated thyroid carcinoma (papillary and follicular) has a favorable prognosis with an 85% 10-year survival. The patients that recur often require surgery and further radioactive iodine to render them disease-free. Five percent of thyroid cancer patients, however, will eventually succumb to their disease. Metastatic thyroid cancer is treated with radioactive iodine if the metastases are radioiodine avid. Cytotoxic chemotherapies for advanced or metastatic noniodine avid thyroid cancers show no prolonged responses and in general have fallen out of favor. Novel targeted therapies have recently been discovered that have given rise to clinical trials for thyroid cancer. Newer aberrations in molecular pathways and oncogenic mutations in thyroid cancer together with the role of angiogenesis in tumor growth have been central to these discoveries. This paper will focus on the management and treatment of metastatic differentiated thyroid cancers that do not take up radioactive iodine.

Autor:innen und Institutionen

  • Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1461, Houston, TX 77030, USA.

Zitieren

APA

Busaidy, N. L., & Cabanillas, M. E. (2012). Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease. Journal of Thyroid Research, 2012, 1-12. https://doi.org/10.1155/2012/618985

Vancouver

Busaidy NL, Cabanillas ME. Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease. Journal of Thyroid Research. 2012;2012:1-12. doi:10.1155/2012/618985

BibTeX
@article{Busaidy2012,
  author = {Busaidy, Naifa Lamki and Cabanillas, Maria E},
  title = {Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease},
  journal = {Journal of Thyroid Research},
  year = {2012},
  volume = {2012},
  pages = {1--12},
  doi = {10.1155/2012/618985}
}
Kostenlos starten →